AKT1 and supranuclear palsy, progressive, 1: As in this case, we identified the AKT1 E17K point mutation through WES analysis, which is a relatively specific molecular feature of PSP (13, 14), but no other common driving gene mutations related to lung cancer were found, which played an important role in strengthening our confidence in the diagnosis of this atypical disease.